Cellevate is an innovative biotech company that develops the next generation of cell culture systems.
Cellevate has raised $2.2M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
Cellevate's investors include European Innovation Council, Almi Invest, Industrifonden, Eurostars, Onsight Ventures.
Cellevate is headquartered in Lund, Sweden.
Cellevate is an innovative biotech company that develops the next generation of cell culture systems.
Cellevate is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cellevate — Funding & Investors." VCBacked, March 30, 2026, https://www.vcbacked.co/company/cellevate. Accessed September 15, 2026.
VCBacked. (2026). Cellevate — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/cellevate
{{cite web |title=Cellevate — Funding & Investors |url=https://www.vcbacked.co/company/cellevate |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated